Explainable Deep Radiogenomic Molecular Imaging for MGMT Methylation Prediction in Glioblastoma

• URL: http://arxiv.org/abs/2601.07035v1
• Date: Sun, 11 Jan 2026 19:16:19 GMT
• Title: Explainable Deep Radiogenomic Molecular Imaging for MGMT Methylation Prediction in Glioblastoma
• Authors: Hasan M Jamil,
• Abstract summary: The methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter is a critical molecular biomarker.<n>Traditional methods for determining MGMT status rely on invasive biopsies.<n>This study presents a radiogenomic molecular imaging analysis framework for the non-invasive prediction of MGMT promoter methylation.
• Score: 0.7614628596146601
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Glioblastoma (GBM) is a highly aggressive primary brain tumor with limited therapeutic options and poor prognosis. The methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter is a critical molecular biomarker that influences patient response to temozolomide chemotherapy. Traditional methods for determining MGMT status rely on invasive biopsies and are limited by intratumoral heterogeneity and procedural risks. This study presents a radiogenomic molecular imaging analysis framework for the non-invasive prediction of MGMT promoter methylation using multi-parametric magnetic resonance imaging (mpMRI). Our approach integrates radiomics, deep learning, and explainable artificial intelligence (XAI) to analyze MRI-derived imaging phenotypes and correlate them with molecular labels. Radiomic features are extracted from FLAIR, T1-weighted, T1-contrast-enhanced, and T2-weighted MRI sequences, while a 3D convolutional neural network learns deep representations from the same modalities. These complementary features are fused using both early fusion and attention-based strategies and classified to predict MGMT methylation status. To enhance clinical interpretability, we apply XAI methods such as Grad-CAM and SHAP to visualize and explain model decisions. The proposed framework is trained on the RSNA-MICCAI Radiogenomic Classification dataset and externally validated on the BraTS 2021 dataset. This work advances the field of molecular imaging by demonstrating the potential of AI-driven radiogenomics for precision oncology, supporting non-invasive, accurate, and interpretable prediction of clinically actionable molecular biomarkers in GBM.

Related papers

• The Multi-View Paradigm Shift in MRI Radiomics: Predicting MGMT Methylation in Glioblastoma [0.0]
  Non-invasive inference of molecular tumor characteristics from medical imaging is a central goal of radiogenomics.<n>We introduce a multi-view latent representation learning framework based on variational autoencoders (VAE) to integrate complementary radiomic features.<n>The proposed approach preserves modality-specific structure while enabling effective multimodal integration.
  arXiv  Detail & Related papers  (2025-12-26T16:32:19Z)
• R-GenIMA: Integrating Neuroimaging and Genetics with Interpretable Multimodal AI for Alzheimer's Disease Progression [63.97617759805451]
  Early detection of Alzheimer's disease requires models capable of integrating macro-scale neuroanatomical alterations with micro-scale genetic susceptibility.<n>We introduce R-GenIMA, an interpretable multimodal large language model that couples a novel ROI-wise vision transformer with genetic prompting.<n>R-GenIMA achieves state-of-the-art performance in four-way classification across normal cognition, subjective memory concerns, mild cognitive impairment, and AD.
  arXiv  Detail & Related papers  (2025-12-22T02:54:10Z)
• Multi-View MRI Approach for Classification of MGMT Methylation in Glioblastoma Patients [6.414625387280682]
  Presence of MGMT promoter methylation significantly affects how well chemotherapy works for patients with Glioblastoma Multiforme (GBM)<n>Currently, confirmation of MGMT promoter methylation relies on invasive brain tumor tissue biopsies.<n>We propose a new multi-view approach that considers spatial relationships between MRI views to detect MGMT methylation status.
  arXiv  Detail & Related papers  (2025-12-16T09:37:20Z)
• Decoding MGMT Methylation: A Step Towards Precision Medicine in Glioblastoma [2.5157401709060063]
  This study introduces the Convolutional Autoencoders for MGMT Methylation Status Prediction framework.<n>The framework is based on adaptive sparse penalties to enhance predictive accuracy.<n>Our method excels in MRI image synthesis, preserving brain tissue, fat, and individual tumor structures.
  arXiv  Detail & Related papers  (2025-08-22T14:32:50Z)
• Style transfer between Microscopy and Magnetic Resonance Imaging via Generative Adversarial Network in small sample size settings [45.62331048595689]
  Cross-modal augmentation of Magnetic Resonance Imaging (MRI) and microscopic imaging based on the same tissue samples is promising.<n>We tested a method for generating microscopic histological images from MRI scans of the human corpus callosum using conditional generative adversarial network (cGAN) architecture.
  arXiv  Detail & Related papers  (2023-10-16T13:58:53Z)
• Genetic InfoMax: Exploring Mutual Information Maximization in High-Dimensional Imaging Genetics Studies [50.11449968854487]
  Genome-wide association studies (GWAS) are used to identify relationships between genetic variations and specific traits. Representation learning for imaging genetics is largely under-explored due to the unique challenges posed by GWAS. We introduce a trans-modal learning framework Genetic InfoMax (GIM) to address the specific challenges of GWAS.
  arXiv  Detail & Related papers  (2023-09-26T03:59:21Z)
• Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging [59.79875531898648]
  DeepGlioma is an artificial-intelligence-based diagnostic screening system. DeepGlioma can predict the molecular alterations used by the World Health Organization to define the adult-type diffuse glioma taxonomy.
  arXiv  Detail & Related papers  (2023-03-23T18:50:18Z)
• Novel Local Radiomic Bayesian Classifiers for Non-Invasive Prediction of MGMT Methylation Status in Glioblastoma [0.0]
  Expression of the O6-methylguanine-DNA-methyltransferase (MGMT) gene in glioblastoma tumor tissue is of clinical importance. Currently, MGMT methylation is determined through an invasive brain biopsy and subsequent genetic analysis of the extracted tumor tissue. We present novel Bayesian classifiers that make probabilistic predictions of MGMT methylation status based on radiomic features extracted from FLAIR-sequence magnetic resonance imagery (MRIs)
  arXiv  Detail & Related papers  (2021-11-30T04:53:23Z)
• Comparison of Machine Learning Classifiers to Predict Patient Survival and Genetics of GBM: Towards a Standardized Model for Clinical Implementation [44.02622933605018]
  Radiomic models have been shown to outperform clinical data for outcome prediction in glioblastoma (GBM) We aimed to compare nine machine learning classifiers to predict overall survival (OS), isocitrate dehydrogenase (IDH) mutation, O-6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, epidermal growth factor receptor (EGFR) VII amplification and Ki-67 expression in GBM patients. xGB obtained maximum accuracy for OS (74.5%), AB for IDH mutation (88%), MGMT methylation (71,7%), Ki-67 expression (86,6%), and EGFR amplification (81,
  arXiv  Detail & Related papers  (2021-02-10T15:10:37Z)
• Confidence-guided Lesion Mask-based Simultaneous Synthesis of Anatomic and Molecular MR Images in Patients with Post-treatment Malignant Gliomas [65.64363834322333]
  Confidence Guided SAMR (CG-SAMR) synthesizes data from lesion information to multi-modal anatomic sequences. module guides the synthesis based on confidence measure about the intermediate results. experiments on real clinical data demonstrate that the proposed model can perform better than the state-of-theart synthesis methods.
  arXiv  Detail & Related papers  (2020-08-06T20:20:22Z)
• Lesion Mask-based Simultaneous Synthesis of Anatomic and MolecularMR Images using a GAN [59.60954255038335]
  The proposed framework consists of a stretch-out up-sampling module, a brain atlas encoder, a segmentation consistency module, and multi-scale label-wise discriminators. Experiments on real clinical data demonstrate that the proposed model can perform significantly better than the state-of-the-art synthesis methods.
  arXiv  Detail & Related papers  (2020-06-26T02:50:09Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.